bioAffinity Technologies, Inc. (NASDAQ:BIAF) Short Interest Down 35.8% in December

bioAffinity Technologies, Inc. (NASDAQ:BIAF) was the recipient of a large drop in short interest in December. As of December 31st, there was short interest totalling 114,000 shares, a drop of 35.8% from the December 15th total of 177,500 shares. Based on an average trading volume of 150,600 shares, the days-to-cover ratio is presently 0.8 days. Currently, 1.2% of the shares of the stock are short sold.

bioAffinity Technologies Price Performance

Shares of NASDAQ BIAF traded down $0.05 during trading on Friday, reaching $0.68. The company had a trading volume of 167,251 shares, compared to its average volume of 393,805. bioAffinity Technologies has a 52 week low of $0.66 and a 52 week high of $3.62. The business’s 50 day moving average price is $1.04 and its 200-day moving average price is $1.59. The stock has a market cap of $10.52 million, a PE ratio of -0.82 and a beta of 2.98. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.01 and a current ratio of 1.02.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.